Baker Tilly’s New Online Market Assessment Tool Helps Life Sciences Companies Use Real-World Data to Pinpoint Commercial Opportunities

A self-service, tailorable-to-you tool, rwdNOW helps life sciences companies keep up with emerging market needs and trends to achieve commercial success.

Download

Loading media player...

CHICAGO--()--Leading advisory CPA firm Baker Tilly US, LLP (Baker Tilly) launches rwdNOW, a customizable, self-service market assessment tool to help life sciences companies pinpoint niche markets with high opportunity levels for the adoption of their products.

“With rising competition in the U.S. market, it is critical for life sciences companies to create a data-driven market access strategy that supports product adoption and coverage at all levels,” said David Gregory, MPA, FACHE, Baker Tilly healthcare consulting industry leader. “Life science organizations need to appropriately develop and integrate a market access strategy that accounts for both current and future market needs and trends to avoid significant hurdles and generate a successful product launch, return on investment and long-term profitability.”

Baker Tilly’s rwdNOW tool leverages Medicare and commercial insurance claims data to provide life sciences companies with insight into payer reimbursement trends and patient resource consumption over time, layered with therapeutic or medical condition details, provider specialty, and patient and referral characteristics.

rwdNOW enables life sciences companies to:

  • Visualize the market size and opportunity
  • Identify characteristics and opportunities of therapeutic categories and conditions
  • Define where the targeted care is being rendered to enable realistic economic opportunity profiles
  • Connect with Baker Tilly market access specialists

“We understand the challenges companies face when identifying attainable markets in which to deploy internal resources to grow market adoption,” Gregory added. “Baker Tilly’s rwdNOW tool enables companies to better understand the market and identify potential changes to achieve their market access goals.”

Learn more about Baker Tilly’s rwdNOW tool at bakertilly.com/specialties/rwdNOW.

About Baker Tilly US, LLP (bakertilly.com)

Baker Tilly US, LLP (Baker Tilly) is a leading advisory, tax and assurance firm, providing clients a genuine coast-to-coast and global advantage with critical mass and top-notch talent in major regions of the U.S. and in many of the world’s leading financial centers – New York, London, San Francisco, Los Angeles and Chicago. Baker Tilly is an independent member of Baker Tilly International, a worldwide network of independent accounting and business advisory firms in 148 territories, with 36,000 professionals and a combined worldwide revenue of $4.0 billion. Visit bakertilly.com or join the conversation on LinkedIn, Facebook and Twitter.

Contacts

Nicole Berkeland
nicole.berkeland@bakertilly.com
612 876 4891

Baker Tilly Media Relations
press@bakertilly.com

Release Summary

Baker Tilly's new tool, rwdNOW helps life sciences companies keep up with emerging market needs and trends to achieve commercial success.

Contacts

Nicole Berkeland
nicole.berkeland@bakertilly.com
612 876 4891

Baker Tilly Media Relations
press@bakertilly.com